Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,215 total articles
Microsoft's mix of high-margin enterprise software, a dominant cloud platform and accelerating AI productization supports a premium valuation. With real-time market quotes not available here, the trade below uses a conservative entry and defined risk controls to capture further multiple expansion while protecting capital.
Adobe has been punished on fears that agentic GenAI will hollow out software licensing. The sell-off paints a better entry: strong cash generation, reasonable valuation, and improving technicals argue for a mid-term long. Trade plan, catalysts, and risk controls included.
International Tower Hill Mines (THM) trades like a levered call on the price of gold. With a market cap around $918M and 259.7M shares outstanding, a relatively small per-share move (about $0.443) equates to roughly $115M of market-cap change. Technical momentum is strong, liquidity is adequate and the stock still sits well below its 52-week high, …
G-III Apparel (GIII) is trading near the middle of its 52-week range but offers unusually strong free cash flow, a low debt load, recent dividend initiation and continued buybacks. These fundamentals plus an improving technical setup support a long trade with a clear entry, stop and target for a 180-trading-day time frame.
Harmony Gold (HMY) trades near $22.78 after a strong metals rally. The company’s gold operations generate meaningful cash flow today while management nudges a copper footprint into view. With a $14.6B market cap, a PE of 17.7 and bullish technicals, HMY offers a medium-risk swing opportunity to capture further upside as gold remains elevated and th…
Allstate is trading cheaply relative to earnings and cash flow after a period of investor concern about margin cyclicality. The business generates nearly $10B of free cash flow, carries modest leverage and trades at a mid-single-digit PE. This trade idea targets a mid-term rebound as P&C margin fears cool and above-average cash returns reassert val…
Match Group is trading below pre-2025 highs on steady free cash flow and a reasonable P/E. At $31.60 the stock offers a low-double-digit upside to a sensible re-rating target and a base dividend yield with potential for a larger capital-return program. This trade idea lays out an entry at $31.60, a $38 target and a $28 stop, with a 180-trading-day …
Boeing looks positioned to accelerate commercial airplane production after signs of renewed order momentum and a favorable industry backdrop. The share base is digesting mixed fundamentals and a high headline valuation, but near-term technicals and order flow create a tradable swing setup. We outline an entry, stop and target with catalysts and a b…
LeMaitre Vascular is a high‑margin, consistently growing specialist in peripheral vascular devices. Recent tempo of innovation, 70% gross margins in Q2 2025 and improving free cash flow make the business a compounding story. The stock has run hard into a 52‑week high but pulled back intraday; this trade idea buys the dip with tight risk controls an…
Visa is trading below its recent moving averages but remains a capital-light, high-margin global payments franchise with strong free cash flow ($22.9B) and a market cap near $605B. This trade idea lays out an entry at $317.54, a stop at $295.00, and a primary target of $360.00 over a 180 trading day horizon, with catalysts, valuation framing, and b…
Swatch Group is an underappreciated play on luxury resilience, brand diversification and margin recovery. We upgrade to Buy and lay out an actionable trade with a $240 entry, $300 target and $200 stop, supported by four concrete catalysts and a balanced risk plan.
TG Therapeutics (TGTX) is a 'Strong Buy' at current levels. BRIUMVI's rapid commercial traction, upgraded 2025 guidance and improving technicals justify a long trade into a 180-day horizon. The plan balances upside to the drug's share gains against execution and regulatory risks with a disciplined stop.
XLP has become the go-to defensive play as investors rotate out of expensive growth. Fundamentals - steady earnings, a 2.45% yield and market-cap concentration in resilient names - combined with technical support argue for a measured long. Entry $89.84, stop $86.00, target $95.00. Hold horizon: long term (180 trading days).
Baldwin Insurance (BWIN) is a beaten-down, diversified insurance broker that has been punished more for narrative risk around AI and headline selling than for its underlying fundamentals. The stock is trading at $22.94 after a big intraday pop on expanding volume. We view current headlines as an overreaction and recommend a mid-term swing long: ent…
Opera (OPRA) is executing on higher-value user monetization and layering AI features into its browser stack. With revenue acceleration in recent quarters, a 5% dividend yield, PE ~17 and a market cap of about $1.43B, the stock offers yield plus upside if execution continues. This is a tactical long with a clear entry, stop and $21.06 target based o…
BitFuFu (BFFU) completed a full operational reset and is now trading at levels that underweight the value of a streamlined core business and potential product relaunch. This trade idea targets a mid-term rebound while keeping a tight stop in case execution stalls.
Root has transformed from a growth story into a profitable, telematics-driven insurer. The stock is down sharply from its 52-week highs and trading near the year low; we present a mid-term swing trade that buys the weakness with a clear stop and a constructive target tied to improving fundamentals and multiple expansion.
Microsoft's fundamentals remain robust - double-digit returns on capital, $77B in free cash flow and manageable leverage - but recent selling has driven sentiment into a more negative zone. That combination creates an asymmetric risk-reward for a mid-term (45 trading days) long. This trade targets a rebound toward fairer multiples while keeping a h…
Iridium has moved off its 2025 low and now shows improving technical momentum, healthy free cash flow and exposure to a growing satellite communications market. We upgrade to a mid-term long with a $22.99 entry, $20.00 stop and $30.00 target — a risk-reward profile we find attractive given current fundamentals and near-term catalysts.
Strategy Inc. (MSTR) trades near $130 after a headline-loss-driven sell-off. The company's operating business shows healthy ROE/ROA and low leverage while the market cap sits ~ $44B. My contrarian view: headline volatility has created an asymmetric risk/reward for a disciplined long. Entry $125, stop $95, target $320 over a 180 trading-day horizon.
Global Industrial (GIC) is trading below recent highs despite resilient margins, positive free cash flow and a healthy balance sheet. At roughly $33, the stock offers a dividend yield of ~3.1%, EV/S near 0.9 and EV/EBITDA ~12.1. This trade targets upside as Indoff integration and e-commerce tailwinds reaccelerate volumes; risk controls focus on inv…
Sprouts Farmers Market (SFM) has been marked down sharply from its 52-week high, but fundamentals — including $467.7M in free cash flow, a 37% return on equity, and a debt-light balance sheet — argue for a long-term buy. This idea lays out an actionable long trade with entry, stop and target, plus the catalysts and risks that will determine whether…
Pandora's strategic shift toward platinum-focused assortments and higher average selling prices presents a tangible margin and brand-repositioning opportunity. This trade idea outlines a mid-term long with entry, stop and target, the fundamental case for why the market should pay up, key catalysts to watch, and the risks that could derail the thesi…
NTB combines a geographically concentrated wealth-and-retail banking franchise, a 3.56% yield, and a sub-10x P/E. We like a long trade: entry $51.00, stop $47.00, target $64.00 over 180 trading days, playing for continued earnings upgrades, dividend stability, and multiple expansion.
Ambev (ABEV) combines a chunky 6.1% yield, margin expansion and a meaningful buyback with constructive technicals. I outline a mid-term trade (45 trading days) to capture further upside while protecting capital with a tight stop. The plan leans on continued margin recovery in Brazil and buyback support, but includes clear triggers that would invali…
